Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Recommendations for evaluating and managing idiopathic pulmonary fibrosis

Recommendations for evaluating and managing idiopathic pulmonary fibrosis ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive and irreversible fibrosis of lung parenchyma that reduces lung function. This rare, incurable disease often is mistaken for an inflammatory condition. IPF typically manifests in older men and is associated with a history of smoking. Disease progression is rapid, with a 5-year survival rate of 20%. Treatment options include lung transplantation and medical therapies to reduce the steady decline in lung function. This article reviews the epidemiology, pathophysiology, presentation, diagnosis, and management of IPF. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the American Academy of PAs Wolters Kluwer Health

Recommendations for evaluating and managing idiopathic pulmonary fibrosis

Loading next page...
 
/lp/wolters-kluwer-health/recommendations-for-evaluating-and-managing-idiopathic-pulmonary-ghJvF952lj

References (33)

Publisher
Wolters Kluwer Health
ISSN
1547-1896
eISSN
0893-7400
DOI
10.1097/01.JAA.0000544299.00459.a4
Publisher site
See Article on Publisher Site

Abstract

ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive and irreversible fibrosis of lung parenchyma that reduces lung function. This rare, incurable disease often is mistaken for an inflammatory condition. IPF typically manifests in older men and is associated with a history of smoking. Disease progression is rapid, with a 5-year survival rate of 20%. Treatment options include lung transplantation and medical therapies to reduce the steady decline in lung function. This article reviews the epidemiology, pathophysiology, presentation, diagnosis, and management of IPF.

Journal

Journal of the American Academy of PAsWolters Kluwer Health

Published: Sep 1, 2018

There are no references for this article.